The SSM Health/Saint Louis University Division of Hematology and Medical Oncology offers a three-year subspecialty fellowship that emphasizes on inpatient and outpatient care, as well as developing ...

Visit us on Facebook. Opens in a new tab or window Visit us on X. Opens in a new tab or window Visit us on Instagram. Opens in a new tab or window Visit us on LinkedIn. Opens in a new tab or ...

Here, Lahoud, clinical associate professor at NYU School of Medicine, section chief of Hematology at NYU Langone Health in ...

Good afternoon and welcome to today's conference call for Omeros Corporation. (Operator Instructions) Please be advised that this call is being recorded at the company's request and a replay will be ...

In the field of myelodysplastic syndromes (MDS), there are a number of investigational studies designed with the hope of ...

(NASDAQ:IRON), a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from serious hematologic diseases, ...

EMERYVILLE, Calif., Nov. 05, 2024 (GLOBE NEWSWIRE) -- Metagenomi, Inc. (Nasdaq: MGX), a precision genetic medicines company committed to developing curative therapeutics for patients using its ...

Reported 100% of Acute Myeloid Leukemia (AML) patients treated in INB-100 remain in complete remission (CR) at the 2024 European Hematology ...

Please refer to the special note regarding forward-looking statements in the company's quarterly report on Form 10-Q, which was filed today with the SEC, and the Risk Factors section of the company's ...

For more information, please visit https:// metageno mi .co. Cautionary Note Regarding Forward‐ Looking Statements This press release contains “forward-looking statements” within the meaning of ...

"Improvements in Hematological Parameters and Quality of Life (QOL) with Elritercept (KER-050): Results from an Ongoing Phase ...